TCG Crossover Management’s Aclaris Therapeutics ACRS Stock Holding History

TCG Crossover Management’s Portfolio ACRS Stock Details ACRS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell
2023 Q2	$5.49M	Hold
2023 Q1	$4.29M	Sell
2022 Q4	$18M	Hold
2022 Q3	$18M	Hold
2022 Q2	$16M	Hold
2022 Q1	$19.7M	Buy
2021 Q4	$15.7M	Buy